Skip to Content


In the US, Telbivudine (telbivudine systemic) is a member of the drug class nucleoside reverse transcriptase inhibitors (NRTIs) and is used to treat Hepatitis B.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Antiviral agent

Nucleoside analogue

Antiviral agent: Treatment of hepatitis B

Chemical Names


1-((2S,4R,5S)-4Hydroxy-5-hydroxymetyltetrahydrofuran-2-yl)-5-metyl-1-H-pyrimidin-2,4-dion (IUPAC)

1-(2-Deoxy-β-L-erytro-pentofuranosyl)-5-metylpyrimidine-2,4(1H,3H)-dione (WHO)



A synthetic thymidine nucleoside analogue; it is the L-isomer of thymidine

tymine, 1-(2-deoxy-beta-L-erytro-pentofuranosyl)-

Foreign Names

  • Telbivudinum (Latin)
  • Telbivudin (German)
  • Telbivudine (French)
  • Telbivudina (Spanish)

Generic Names

  • Telbivudine (OS: BAN, USAN)
  • beta-L-Thymidine (IS)
  • Epavudine (IS)
  • LdT (IS)
  • LDT 600 (IS)
  • L-Thymidine (IS)
  • NB 02B (IS)
  • NV-02B (IS: NovirioPharmac)

Brand Names

  • Sebivo
    Novartis, Bangladesh; Novartis, China; Novartis, France; Novartis, Georgia; Novartis, Greece; Novartis, Hong Kong; Novartis, Croatia (Hrvatska); Novartis, Indonesia; Novartis, Israel; Novartis, Lebanon; Novartis, Malaysia; Novartis, Netherlands; Novartis, Norway; Novartis, Oman; Novartis, Poland; Novartis, Portugal; Novartis, Romania; Novartis, Serbia; Novartis, Sweden; Novartis, Slovenia; Novartis, Thailand; Novartis, Turkey; Novartis, Taiwan; Novartis Europharm, Austria; Novartis Farma, Italy; Novartis Farmaceutica, Spain; Novartis Healthcare, Philippines; Novartis Pharma, Switzerland; Novartis Pharma, Germany; Novartis Pharmaceuticals, Australia; Novartis Pharmaceuticals, Canada; Novartis Pharmaceuticals UK, United Kingdom; Novartis, Argentina; Novartis, Lithuania
  • Tyzeka
    Idenix, United States; Novartis, United States


BANBritish Approved Name
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.